Pharmaceutical

West Pharma Soars Amid GLP-1 Drug Demand; Mixed Market Results
Clinical & Pharma West Pharma Soars Amid GLP-1 Drug Demand; Mixed Market Results

West Pharmaceutical Services has experienced significant financial success, with a notable 23.15% increase in its stock price, reaching $279.26. This surge is primarily driven by a higher-than-expected earnings report, surpassing Wall Street projections and signaling robust demand for its products.

Will Africa's Pharma Market Hit $118 Billion by 2032?
Clinical & Pharma Will Africa's Pharma Market Hit $118 Billion by 2032?

Africa's pharmaceutical market is on the cusp of a transformative era, projected to expand from USD 64.2 billion in 2025 to USD 118.3 billion by 2032, at an impressive CAGR of 9.10%. The surge in this sector is largely attributed to an increase in chronic disease cases, improvements in regulatory

Does Central Drug Store's Closure Signal End of an Era?
Clinical & Pharma Does Central Drug Store's Closure Signal End of an Era?

In recent events that resonate deeply with those who value community over corporate, the closure of Central Drug Store, a San Francisco icon, marks the end of a quintessential American mainstay. For 117 years, this independent pharmacy stood resilient against the tide of vast retail chains, proving

New Class of Ultra-Stable Chiral Molecules Revolutionizes Drugs
Clinical & Pharma New Class of Ultra-Stable Chiral Molecules Revolutionizes Drugs

In a monumental stride for pharmaceutical chemistry, researchers have developed a groundbreaking new class of ultra-stable chiral molecules that could redefine drug efficacy and safety. Chiral molecules, akin to a pair of gloves where the left and right hands are mirror images, play a pivotal role

Is Gene Editing the Future of Cardiovascular Treatment?
Clinical & Pharma Is Gene Editing the Future of Cardiovascular Treatment?

In an era marked by rapid advancements in biotechnology, gene editing emerges as a promising frontier in the treatment of cardiovascular diseases. With the acquisition of Verve Therapeutics by Eli Lilly and Co., the pharmaceutical industry witnesses a strategic shift as major players venture deeper

Can AI Accelerate Alzheimer's Clinical Trials?
Clinical & Pharma Can AI Accelerate Alzheimer's Clinical Trials?

The integration of artificial intelligence into Alzheimer's research has ignited significant interest as researchers seek innovative ways to enhance the efficiency and effectiveness of clinical trials. One study spearheaded by researchers at the University of Cambridge has gained attention,

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later